Professor Martin Housset, radiotherapist at the Georges Pompidou European Hospital (AP-HP), describes the importance and progress of current and future radiotherapy. This technology that can be scary has evolved considerably in precision with extremely reduced toxicity. By combining different techniques, it is now possible to adapt radiotherapy according to the evolution of the tumor during treatment. New techniques, such as stereo-radiotherapy, will allow development of personalized medicine in radiotherapy.

Acute Myeloid Leukemia: identification of a new targeted therapy approach
Acute myeloid leukemia (AML) is a hematologic malignancy that develops from hematopoietic stem
